Quantcast

Latest Pancreas Stories

2014-09-10 08:29:58

ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ssAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D). The two-year study, which will enroll eight participants at Uppsala University Hospital in Sweden, will evaluate the safety, survival and function of implanted human islets...

2014-09-03 08:34:51

Medical device provides at-home A1c monitoring in less than 5 minutes INDIANAPOLIS, Sept. 3, 2014 /PRNewswire/ -- Consumers now have the ability to test their A1c from home in less than 5 minutes thanks to Chek Diagnostics' introduction of the A1CNow SELFCHECK system. http://photos.prnewswire.com/prnvar/20140327/DE91354LOGO A1CNow SELFCHECK is a consumer-friendly medical device that provides a fast, easy and accurate at-home testing method for obtaining HbA1c results. In just five minutes,...

2014-08-30 23:02:07

The Firm is evaluating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of the medication. New York, New York (PRWEB) August 30, 2014 Hundreds of Byetta lawsuits (http://www.byettalawsuit.com) and other incretin mimetic claims continue to move forward in U.S. courts, Bernstein Liebhard LLP reports. According to a statement issued by AstraZeneca PLC on July 31, 2014, Byetta and Bydureon (an extended-release...

2014-08-15 23:00:59

The Firm is actively investigating Januvia and Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis and other serious injuries after taking either of the diabetes treatments. New York, NY (PRWEB) August 15, 2014 Healthcare regulators in British Columbia have stopped patient coverage of a diabetes drug now involved in hundreds of Byetta lawsuits (http://www.byettalawsuit.com/) as well as several other medications, Bernstein Liebhard LLP reports....

type-1 diabetes
2014-08-01 02:00:43

Susan Gammon, Ph.D., Sanford-Burnham Medical Research Institute A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes—insulin-producing beta cells. The study, published online July 31 in Cell Death and Disease, suggests a new approach to treating the estimated 3 million people in the U.S., and over 300 million worldwide,...

2014-07-14 16:24:30

Anthera to Form a New Subsidiary, Alkira Therapeutics, to Assume All Development Activities and Registration Activities as a Subsidiary of Anthera HAYWARD, Calif., July 14, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company. Sollpura is a soluble, stable and non-porcine enzyme product intended for the treatment...

2014-07-14 08:26:56

The registry will bring together data from patients and cutting-edge researchers, all working to improve care and develop new and better therapies for individuals suffering from pancreatic diseases SALT LAKE CITY, July 14, 2014 /PRNewswire/ -- Remedy Informatics, the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced that it has teamed up with the National Pancreas Foundation (NPF) to build the first-ever...

2014-07-02 10:16:43

APS A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent). GRP78, a protein that protects cells from dying, is more abundant in cancer cells and tissue than in normal organs and is thought to play a role in helping pancreatic cancer cells survive and thrive. Researchers at...

2014-06-17 08:28:03

Nearly 500 Pancreatic Cancer Advocates Head to Capitol Hill Today MANHATTAN BEACH, Calif., June 17, 2014 /PRNewswire/ -- Nearly 500 people from across the country are on Capitol Hill today for the eighth annual Pancreatic Cancer Advocacy Day urging Congress to stomp on pancreatic cancer by stepping up federal research funding. Advocates from the Pancreatic Cancer Action Network will call on Congress to provide $5.26 billion for the National Cancer Institute (NCI) for FY15 and...

2014-05-29 08:30:19

SAN DIEGO, May 29, 2014 /PRNewswire/ -- "She has no evidence of cancer of any kind!" In the encouraging wake of her doctor's words, Rivi Litvin stepped out of a leading Los Angeles hospital, knowing that her prayers had been answered. http://photos.prnewswire.com/prnvar/20140528/91775 A year earlier, in September 2012, Rivi approached her doctors with persistent symptoms of abdominal pain, nausea and jaundice. Their fear that these may be symptoms of pancreatic cancer were realized...


Latest Pancreas Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related